Business News

Exclusive; Puneet Goenka alleges Invesco is seeking control over Zee board and merger with Sony

Punit Goenka, overseeing chief and CEO of Zee Entertainment Enterprises (ZEE), has claimed that Invesco, the biggest partner of the…

4 years ago

Supreme Court to Centre: How did you fix Rs 8 Lakh as Economically Weaker Sections quota ceiling?

The Supreme Court has requested that the Center clarify how it fixed ₹8 lakh as pay limit for deciding if…

4 years ago

Berkshire Hathaway, Ratan Tata among major investors looking to exit Paytm in record IPO

The majority of Paytm's enormous benefactors, including industrialist Ratan Tata, Alibaba, SoftBank and Berkshire Hathaway are hoping to sell somewhere…

5 years ago

Are balanced and aggressive hybrid funds going out of favour?

Asset streams for adjusted and forceful half and half assets plunged for the 6th month straight, the month to month…

5 years ago

Chennai’s Le Meridien hotel has a new owner after NCLT order

The notable Le Meridien inn at Guindy in Chennai is set to change hands. The Chennai part of the National…

5 years ago

Ahmedabad-based clinical research organisation Veeda acquires controlling stake in Bioneeds

Veeda Clinical Research, the Ahmedabad-based clinical exploration association (CRO), has procured a controlling 50.1 percent stake in Bioneeds India Private…

5 years ago

Swiggy goes the Peppo, DotPe way; pilots ‘order direct’ in Mumbai

Bowing to the consistent interest of eateries, online food-conveyance specialist organization Swiggy has begun guiding 'request direct' in association with…

5 years ago

Why did hybrid, GenNext and Digital India theme funds invest in Zomato’s IPO?

A look at the rundown of anchor financial backers for the first sale of stock (IPO) of Zomato shares hurls…

5 years ago

Stock exchanges examining preferential share issue to parent: LIC Housing Finance

he lodging finance arm of state-run Life Insurance Corp, LIC Housing Finance, on Saturday said stock trades are analyzing its…

5 years ago

Serum Institute hasn’t applied for full marketing approval of Covishield in Europe

Serum Institute of India (SII) hasn't applied for full showcasing authorisation of Covishield in Europe, as it doesn't consider it…

5 years ago

This website uses cookies.